All Stories

  1. Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality

    Article • Human Vaccines & Immunotherapeutics, April 2019, Taylor & Francis

    Stefan Kaufmann

  2. Indole Propionic Acid: a Small Molecule Links between Gut Microbiota and Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, April 2018, ASM Journals

    Stefan Kaufmann

  3. Status of TB vaccine development

    Article • F1000Research, February 2018, Faculty of 1000, Ltd.

    Dr Helen A Fletcher, Stefan Kaufmann, Gerald Voss

  4. Biomarkers help to speed up the development of a tuberculosis vaccine

    Article • Expert Review of Vaccines, June 2017, Taylor & Francis

    Stefan Kaufmann, Dr January 3rd Weiner

  5. Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes

    Article • mBio, February 2017, ASM Journals

    Stefan Kaufmann

  6. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis

    Article • mBio, November 2016, ASM Journals

    Stefan Kaufmann

  7. Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+Dendritic Cells Confers Transient Susceptibility to Tuberculosis

    Article • Infection and Immunity, August 2016, ASM Journals

    Stefan Kaufmann

  8. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG Δ ureC :: hly Improves P...

    Article • mBio, May 2016, ASM Journals

    Stefan Kaufmann

  9. Epigenetics and Proteomics Join Transcriptomics in the Quest for Tuberculosis Biomarkers

    Article • mBio, September 2015, ASM Journals

    Stefan Kaufmann

  10. TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: ‘How can big data help?’

    Article • Vaccine, July 2014, Elsevier

    Dr Helen A Fletcher, Stefan Kaufmann

  11. Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice

    Article • mBio, June 2014, ASM Journals

    Stefan Kaufmann

  12. Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

    Article • Vaccine, February 2013, Elsevier

    Stefan Kaufmann